Evidence map›Paper›PMID 19218483›Full record

ArticleJournal of leukocyte biology2009

IFN-gamma-indoleamine-2,3 dioxygenase acts as a major suppressive factor in 4-1BB-mediated immune suppression in vivo.

Young H Kim, Beom K Choi, Woo J Kang, Kwang H Kim, Sang W Kang, Andrew L Mellor, David H Munn, Byoung S Kwon

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Young H KimDivision of Cell and Immunobiology and R&D Center for Cancer Therapeutics, National Cancer Center, Kyonggi-do, Korea.
Beom K Choi
Woo J Kang
Kwang H Kim
Sang W Kang
Andrew L Mellor
David H Munn
Byoung S Kwon
National Cancer Center · KRAugusta University · USUniversity of Ulsan · KR

Funding

Ocular HSV-1, Stromal Keratitis, &T Cell CostimulationR01EY013325 · NEI · LSU HEALTH SCIENCES CENTER · PI KWON, BYOUNG S · 2002 to 2006
$1.5M
NEI NIH HHS R001EY013325NEI NIH HHS R01 EY013325
6 · The paper itself

Abstract

It has been reported that 4-1BB triggering in vivo selectively suppressed the recall response of staphylococcal enterotoxin A (SEA)-specific CD4(+) T cells, in which CD8(+) T-derived TGF-beta was involved. Here, we have examined an alternative mechanism for the 4-1BB-mediated CD4(+) T suppression, as the neutralization of TGF-beta is only effective in rescuing the SEA-specific recall response at high cellular concentrations. We show that this selective suppression of CD4(+) T cells by 4-1BB triggering in vivo is mediated mainly by induction of indoleamine 2,3-dioxygenase (IDO) in an IFN-gamma-dependent manner. SEA-specific CD4(+) T responses were suppressed partly by TGF-beta-expressing CD8(+) T cells, particularly CD11c(+)CD8(+) T cells, but strongly inhibited by dendritic cells (DCs) expressing IDO. IFN-gamma that increased IDO in DCs was produced primarily from CD11c(+)CD8(+) T cells, which were expanded selectively by 4-1BB stimulation. CD4(+), CD8(+), and plasmacytoid DCs exerted a similar suppressive activity toward the SEA-specific CD4(+) T cells. Neutralization of IFN-gamma or IDO activity in vivo largely reversed the 4-1BB-mediated CD4(+) T suppression. Collectively, these data indicate that 4-1BB-dependent suppression of SEA-specific CD4(+) T responses was mediated mainly by IFN-gamma-dependent IDO induction and partially by TGF-beta.

Indexed as

Immunosuppression Therapy4-1BB LigandAnimalsAntibodies, MonoclonalCD11c AntigenCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDendritic CellsEnterotoxinsIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutTransforming Growth Factor beta4-1BB LigandAntibodies, MonoclonalCD11c Antigenenterotoxin A, StaphylococcalEnterotoxinsIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaTransforming Growth Factor beta

Identifiers

PMID19218483
PMCPMC2669405
OpenAlexW2162982747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.